Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ztalmy
Pharma
Immedica Pharma picks up troubled Marinus in $151M deal
The buyout spells the end of Marinus' review of strategic alternatives following two key phase 3 misses.
Zoey Becker
Jan 2, 2025 11:50am
Marinus trims workforce by 45% after pair of clinical stumbles
Nov 13, 2024 11:26am
Marinus to end further Ztalmy development after another trial miss
Oct 24, 2024 12:30pm
With investor lawsuit and trial flop, troubles mount for Marinus
Jun 17, 2024 4:33pm
Once on the scrapheap, Marinus' seizure drug wins FDA approval
Mar 18, 2022 6:48pm
